pillbase.ru

Austedo

Active substance: deutetrabenazine

deutetrabenazine

Centralised EU authorisationActive

Marketing holder: Teva GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 13
  • AUSTEDO
    KIT · deutetrabenazine
    68546-176
    Teva Neuroscience, Inc.
  • AUSTEDO XR
    TABLET, FILM COATED, EXTENDED RELEASE · DEUTETRABENAZINE 42 mg/1
    68546-475
    Teva Neuroscience, Inc.
  • AUSTEDO XR
    TABLET, FILM COATED, EXTENDED RELEASE · DEUTETRABENAZINE 36 mg/1
    68546-474
    Teva Neuroscience, Inc.
  • AUSTEDO XR
    TABLET, FILM COATED, EXTENDED RELEASE · DEUTETRABENAZINE 48 mg/1
    68546-476
    Teva Neuroscience, Inc.
  • AUSTEDO XR
    TABLET, FILM COATED, EXTENDED RELEASE · DEUTETRABENAZINE 24 mg/1
    68546-472
    Teva Neuroscience, Inc.
All products in this country (13)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-a737-7833-b1e0-f83372f3145b,01a1208d-8f6a-759f-81f0-af080eeb4f53,01a1208d-8f74-7355-b237-0f5d587fb6cb,01a1208d-8f78-7ee0-b107-0c53c12c99d6,01a1208e-bfc3-76d5-84ba-baa7206223dd;count=13 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006371
Registration status
Active
ATC code
N07XX16
Sources
  • product · EMA · EMEA/H/C/006371 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006371 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006371 · Verified 2026-10-09